| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $1.21 (Beat by $0.2) |
| EPS GAAP Actual | $1.21 (Beat by $0.2) |
| Revenue Actual | $0.213611B |
| Revenue Surprise | Beat by $213.611M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.15833 |
| EPS GAAP Estimate | $2.15833 |
| Revenue Estimate | $0.3211B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 4.87 | 17.61 | 4.68047 | 4.99133 | 1 |
| Dec 2026 | 11.5 | 7.46 | 10.84912 | 11.90177 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.83 | -1.135 | 0.213611B | -20.11% | -89.39M |
| FQ2 2025 (Jun 2025) | 0.98 | -1.07 | 0.194544B | -31.85% | -113.2M |
| FQ1 2025 (Mar 2025) | 0.89 | -0.91714 | 0.192563B | -31.06% | -94.09M |
| FQ4 2024 (Dec 2024) | 1.54 | 1.54 | 0.252417B | -22.93% | 252.42M |
| FQ3 2024 (Sep 2024) | 1.49 | 1.49 | 0.256564B | -13.94% | 256.56M |
| FQ2 2024 (Jun 2024) | 1.56 | 1.56 | 0.256512B | -6.81% | 256.51M |
| FQ1 2024 (Mar 2024) | 1.58 | 1.58 | 0.252372B | -0.65% | 252.37M |
| FQ4 2023 (Dec 2023) | 2.17 | 2.17 | 0.310288B | 14.26% | 310.29M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.15833
Consensus Revenue Estimates
0.3211B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.34 | -- | 1.22875 | 1.36609 | 2 |
| FQ3 2027 (Sep 2027) | 1.26 | -- | 1.15539 | 1.28453 | 2 |
| FQ2 2027 (Jun 2027) | 1.18 | -- | 1.08203 | 1.20297 | 2 |
| FQ1 2027 (Mar 2027) | 1.08 | -- | 0.99034 | 1.10103 | 2 |
| FQ4 2026 (Oct 2026) | 2.87 | -- | 2.68304 | 3.03342 | 1 |
| FQ3 2026 (Jul 2026) | 2.88 | 71.18 | 2.69239 | 3.04399 | 1 |
| FQ2 2026 (Jun 2026) | 2.88 | 65.97 | 2.81528 | 2.99654 | 1 |
| FQ1 2026 (Mar 2026) | 2.82 | 68.44 | 2.75663 | 2.93411 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.23B | -- | 0.21B | 0.23B | 3 |
| FQ3 2027 (Sep 2027) | 0.22B | -- | 0.21B | 0.22B | 3 |
| FQ2 2027 (Jun 2027) | 0.22B | -- | 0.2B | 0.22B | 3 |
| FQ1 2027 (Mar 2027) | 0.21B | -- | 0.2B | 0.21B | 3 |
| FQ4 2026 (Oct 2026) | 0.38B | -- | 0.36B | 0.39B | 2 |
| FQ3 2026 (Jul 2026) | 0.38B | 43.04 | 0.36B | 0.39B | 2 |
| FQ2 2026 (Jun 2026) | 0.38B | 48.12 | 0.37B | 0.39B | 2 |
| FQ1 2026 (Mar 2026) | 0.37B | 47.96 | 0.36B | 0.38B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.965 | 0.83 | -1.135 | -136.75% |
| FQ2 2025 (Jun 2025) | 2.05 | 0.98 | -1.07 | -109.18% |
| FQ1 2025 (Mar 2025) | 1.80714 | 0.89 | -0.91714 | -103.05% |
| FQ4 2024 (Dec 2024) | 1.54 | 1.54 | 100% | |
| FQ3 2024 (Sep 2024) | 1.49 | 1.49 | 100% | |
| FQ2 2024 (Jun 2024) | 1.56 | 1.56 | 100% | |
| FQ1 2024 (Mar 2024) | 1.58 | 1.58 | 100% | |
| FQ4 2023 (Dec 2023) | 2.17 | 2.17 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.3B | $0.21B | $-89.39M | -41.85% |
| FQ2 2025 (Jun 2025) | $0.31B | $0.19B | $-113.2M | -58.19% |
| FQ1 2025 (Mar 2025) | $0.29B | $0.19B | $-94.09M | -48.86% |
| FQ4 2024 (Dec 2024) | $0B | $0.25B | $252.42M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.26B | $256.56M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.26B | $256.51M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.25B | $252.37M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.31B | $310.29M | 100% |